Phenotypes of the no-reflow phenomenon during percutaneous coronary interventions in myocardial infarction

被引:0
|
作者
Frolov, A. A. [1 ,2 ]
Frolov, I. A. [1 ,2 ]
Ulanova, N. D. [2 ]
Pochinka, I. G. [1 ,2 ]
Kuzmichev, K., V [1 ,2 ]
Mukhin, A. S. [1 ]
Sharabrin, E. G. [1 ]
机构
[1] Privolzhsky Res Med Univ, 10-1 Minina & Pozharskogo Sq,POB 470, Nizhnii Novgorod 603950, Russia
[2] City Clin Hosp 13 Nizhny Novgorod Avtozavodskoy D, 51 Patriotov Str, Nizhnii Novgorod 603018, Russia
来源
BYULLETEN SIBIRSKOY MEDITSINY | 2023年 / 22卷 / 04期
关键词
no-reflow phenomenon; myocardial infarction; percutaneous coronary intervention; cluster analysis; classification; ST-SEGMENT ELEVATION;
D O I
10.20538/1682-0363-2023-4-137-146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. Using the cluster analysis, to determine and describe clinical and pathogenetic phenotypes of the coronary microvascular obstruction phenomenon (CMVO) that occurs during percutaneous coronary interventions (PCI) in patients with myocardial infarction (MI). Materials and methods. The study included 190 patients with CMVO that occurred during PCI for type 1 MI: 137 (72%) men, 53 (28%) women, the median age was 64 [56; 70] years. The study was conducted in 2013-2020. CMVO criteria: blood flow < 3 points in the infarct-related artery (IRA) according to the TIMI flow grade (TFG); perfusion < 2 points according to the Myocardial Blush Grade; ST segment resolution < 70%. ST-elevation MI (STEMI) was found in 170 patients (89%). Primary PCI was noted in 127 (67%) cases. Nine patients (4.7%) died. Phenotyping was performed using the expectation - maximization (EM) algorithm. Results. Three phenotypes were identified in a ratio of 56% (n = 106) / 27% (n = 52) / 17% (n = 32). The values of the parameters are the following, respectively: age 62 [54; 67] / 73 [67; 79] / 59 [50; 65] years; women 8 (8%) / 39 (77%) / 6 (19%); STEMI 102 (96%) / 43 (83%) / 25 (78%); thrombolysis 46 (43%) / 6 (12%) / 11 (34%); class 1 [1; 2] / 2 [1; 4] / 2 [2; 2] acute heart failure; platelet-to-lymphocyte ratio 110 [78; 153] / 106 [85; 132] / 132 [100; 182]; glucose at admission 8.0 [6.9; 9.6] / 11.1 [8.8; 15.2] / 7.5 [6.1; 8.1] mmol / l; total cholesterol 4.7 [4.2; 5.4] / 5.3 [3.7; 6.2] / 5.1 [4.5; 6.2] mmol / l; glomerular filtration rate according to CKD-EPI 77 [64; 88] / 58 [46; 74] / 81 [64; 88] ml /min / 1.73m(2); Syntax Score 15 [10; 21] / 20 [14; 26] / 8 [5; 10]; Syntax Score in the IRA 9 [8; 15] / 12 [7; 16] / 6 [3; 7]; coronary collaterals according to Rentrop: grade 0 [0; 1] / 0 [0; 1] / 0 [0; 0]; thrombosis of the IRA according to the TIMI thrombus grade 5 [5; 5] / 5 [3; 5] / 1 [0; 2]; TFG 0 [0; 0] / 0 [0; 1] / 2 [2; 3]; aspiration thrombectomy 30 (28%) / 7 (13%) / 4 (13%); IRA diameter 3.5 [3.0; 3.5] / 3.0 [2.8; 3.5] / 3.5 [3.0; 3.5] mm; balloon angioplasty 99 (93%) / 45 (87%) / 16 (50%); PCI of 2 or more arteries 0 (0%) / 4 (8%) / 3 (9%). Deaths - 2 (1.9%), 7 (13.5%), and 0 (0%) patients, respectively (p = 0.002,chi 2 Pearson). Conclusion. Three phenotypes were identified. Phenotype 1: severe IRA thrombosis, mostly men, moderate atherosclerotic lesions. Phenotype 2: mostly elderly women, high hyperglycemia, severe atherosclerotic lesions, severe AHF, impaired renal function, IRA thrombosis. Phenotype 3: mostly men, minor changes in the coronary arteries, absence of significant thrombosis and preserved blood flow in the IRA before PCI, elevated levels of inflammatory markers and total cholesterol.
引用
收藏
页码:137 / 146
页数:10
相关论文
共 50 条
  • [1] The impact of slow or no-reflow phenomenon during percutaneous coronary intervention with thrombus aspiration for acute myocardial infarction
    Hyodo, Y.
    Kadota, K.
    Otsuru, S.
    Hasegawa, D.
    Habara, S.
    Tada, T.
    Tanaka, H.
    Fuku, Y.
    Goto, T.
    Mitsudo, K.
    EUROPEAN HEART JOURNAL, 2014, 35 : 825 - 825
  • [2] Effects of different vasodilators on no-reflow phenomenon during percutaneous coronary intervention in patients with acute myocardial infarction
    Huang, D.
    Ma, J.
    Zhang, F.
    Wang, X.
    Ge, L.
    Qian, J.
    Ge, J.
    EUROPEAN HEART JOURNAL, 2009, 30 : 248 - 249
  • [3] Incidence and Outcomes of No-Reflow Phenomenon During Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction
    Harrison, Robert W.
    Aggarwal, Atul
    Ou, Fang-shu
    Klein, Lloyd W.
    Rumsfeld, John S.
    Roe, Matthew T.
    Wang, Tracy Y.
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (02): : 178 - 184
  • [4] Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction
    Pasceri, V
    Pristipino, C
    Pelliccia, F
    Granatelli, A
    Speciale, G
    Roncella, A
    Pironi, B
    Capasso, M
    Richichi, G
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (11): : 1358 - 1361
  • [5] COMPARISON OF THE EFFECTS OF NITROPRUSSIDE VERSUS NICORANDIL ON THE SLOW/NO-REFLOW PHENOMENON DURING CORONARY INTERVENTIONS FOR ACUTE MYOCARDIAL INFARCTION
    Sato, Tetsuya
    Fuke, Soichiro
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E535 - E535
  • [6] Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction
    Renpei Kobatake
    Tetsuya Sato
    Yasukazu Fujiwara
    Haruki Sunami
    Ryo Yoshioka
    Tetsuya Ikeda
    Hironori Saito
    Toru Ujihira
    Heart and Vessels, 2011, 26 : 379 - 384
  • [7] Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction
    Kobatake, Renpei
    Sato, Tetsuya
    Fujiwara, Yasukazu
    Sunami, Haruki
    Yoshioka, Ryo
    Ikeda, Tetsuya
    Saito, Hironori
    Ujihira, Toru
    HEART AND VESSELS, 2011, 26 (04) : 379 - 384
  • [8] Epinephrine for Refractory No-Reflow During Percutaneous Coronary Interventions
    Alfonso, Fernando
    Gomez-Lara, Josep
    Rivero, Fernando
    AMERICAN JOURNAL OF CARDIOLOGY, 2025, 235 : 88 - 90
  • [9] Angiographic no-reflow phenomenon in the patients with acute myocardial infarction after percutaneous transluminal coronary intervention
    Oikawa, M
    Komatsu, N
    Shiratori, Y
    Kunii, H
    Yamao, H
    Namiuti, S
    Sugi, M
    Yui, M
    Ichihara, T
    Maruyama, Y
    Kyouritsu, I
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 246A - 246A
  • [10] Predictor of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.
    Hong, Y. J.
    Jeong, M. H.
    Ahn, Y. X.
    Kim, J. H.
    Sim, D. S.
    Yoon, N. S.
    Kang, J. C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8B): : 26C - 27C